Literature DB >> 6941379

Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.

S J Konturek, W Obtulowicz, N Kwiecień, M Dobrzańska, J Swierczek, B Kopp, J Olesky.   

Abstract

The effects of atropine and pirenzepine on sham-feeding stimulated gastric secretion and serum gastrin and pancreatic polypeptide levels have been studied in 12 patients with duodenal ulcer. Both atropine and pirenzepine caused a dose-dependent decrease in acid and pepsin secretion induced by sham-feeding. Serum gastrin response to sham-feeding was negative and it was enhanced by atropine but suppressed by pirenzepine. Plasma pancreatic polypeptide level, which was markedly increased by sham-feeding, was abolished both by atropine and pirenzepine. This study shows that pirenzepine is a more selective inhibitor of gastric secretory and serum hormonal responses to sham-feeding than atropine and that it may be a useful tool for studying the cholinergic innervation of the oxyntic glands and the G-cells in man.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6941379

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  10 in total

1.  Effects of pirenzepine on omeprazole-induced gastrin gene expression in rat antral tissues.

Authors:  A Tari; M Hamada; T Kamiyasu; Y Fukino; M Sumii; K Sumii; G Kajiyama
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Subtypes of muscarinic receptors in canine pancreatic secretion in vivo and in vitro.

Authors:  S J Konturek; J Jaworek; J Tasler; M Cieszkowski; N Yanaihara
Journal:  Int J Pancreatol       Date:  1987-02

3.  Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.

Authors:  W Londong; V Londong; C Federle; P Tanswell; U Voderholzer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Newer antisecretory agents for peptic ulcer.

Authors:  K W Somerville; M J Langman
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

5.  Atropine and verapamil interactions in healthy volunteers.

Authors:  E C Meyer; D K Sommers; J C Avenant
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.

Authors:  W Londong; V Londong; C Ruthe; P Weizert
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

7.  Possible mechanisms of anti-cholinergic drug-induced bradycardia.

Authors:  E C Meyer; D K Sommers
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 8.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

9.  Serum gastrin levels following administration of omeprazole alone or in combination with pirenzepine.

Authors:  A Iwasaki; K Miyazawa; Y Kawamura; Y Sakai; Y Tashiro; K Ito; Y Arakawa; Y Matsuo
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

10.  Effect of enkephalin and naloxone on gastric acid and serum gastrin and pancreatic polypeptide concentrations in humans.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; J Swierczek; W Bielański; J Oleksy; D H Coy
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.